نتائج البحث 51-60 من 2244 لعملية البحث عن anti-TNF drugs
Drugs used in chemotherapy, such as lenalidomide ... anti-PD (programmed death)-1 monoclonal antibody ... This study will compare the use of hypofraction proton ...
Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...
Chemotherapy and radiation therapy may reduce the tumor size and the amount of normal tissue that needs to be removed during surgery. A combined treatment with ...
... drugs as a way of overcoming these limitations. This study will determine the effectiveness of the triple combination therapy, DTRM-555, in patients with R ...
Anti-cancer activity will be assessed every 6 weeks during therapy and every 12 weeks thereafter. Establishment of Preclinical Models from Patients with ...
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
Page 1.
This project will investigate whether the analysis of nucleic acids circulating in the blood from tumors can allow real-time monitoring of treatment response to ...
Chemotherapy drugs, such as carboplatin and ... Giving atezolizumab with usual treatment may work better than usual treatment alone. ... anti-T-cell immunoglobulin ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.